CJC 1295 no DAC + Ipamorelin 5mg/5mg

CJC-1295 (No DAC) + Ipamorelin is a precisely formulated research peptide blend containing equal amounts of two synergistic growth hormone releasing peptides in a single convenient vial. Each vial contains 5mg of CJC-1295 (without DAC) and 5mg of Ipamorelin for a total of 10mg of active peptide content.

Dual Peptide Composition: This research blend combines CJC-1295 (No DAC), a growth hormone releasing hormone analog, with Ipamorelin, a selective growth hormone secretagogue receptor agonist. The 1:1 ratio of 5mg CJC-1295 and 5mg Ipamorelin in each vial provides researchers with a standardized dual-pathway approach for studying growth hormone release mechanisms.

Key Research Applications: Growth hormone pathway investigation, peptide synergy studies, receptor specificity research, circadian rhythm analysis, and comparative peptide pharmacology studies.

Product Specifications: Purity ≥98% (HPLC verified for both peptides), white lyophilized powder form, storage at -20°C with protection from light, Certificate of Analysis included showing individual peptide content verification.

Research Notes: The combination allows researchers to study both GHRH receptor activation (CJC-1295) and ghrelin receptor activation (Ipamorelin) simultaneously. Each peptide maintains its individual properties while providing potential synergistic effects for comprehensive growth hormone research applications.

Important: For research use only. Not for human consumption or therapeutic use. Must be handled by qualified researchers in appropriate laboratory settings.

Research grade, dual-peptide verified, comprehensive documentation included.